What matters most is the beautiful mind of the scientist – International Day of Women and Girls in Science 2025
Since 2015, February 11th has been celebrated as the UN Day for Women and Girls in Science and Technology, a day dedicated to highlighting the achievements of women in STEM and inspiring future generations to follow their lead. In previous years, we’ve heard from incredible women like our COO Vilhelmiina Juusti and Senior Application Scientist Elizabeth Cudjoe. This year, we are excited to spotlight Elinda Hermanson, our newest / youngest Application Scientist, who shares her journey in biotechnology and her thoughts on empowering women in science.
Nordic Tech and Innovation leader Pia Erkinheimo Appointed Chairperson of the Board at Aqsens Health – An Interview with Pia Erkinheimo
Aqsens Health, the inventor of the groundbreaking phage-biosensor method, is pleased to announce the appointment of Pia Erkinheimo as the Chairperson of the Board of Directors. Her leadership roles in high tech, experience in building up businesses, and connections to the innovation ecosystems both in the Nordics and Europe will open up new opportunities for Aqsens Health and complement our board of directors with valuable insights.
Aqsens Health’s new insider in Boston – Uzma Riyaz joins the team as a Project Coordinator
Aqsens Health is pleased to welcome Uzma Ryiaz to the team. Uzma joins Aqsens Health as a Project Coordinator, initially supporting our research collaboration with Harvard Medical School in Boston, and later expanding to other projects in the area.
Could biosensors enable better prediction for organ transplantation rejection – a research project with the Department of Medicine, Harvard Medical School Lung Transplantation team
Aqsens Health had a chance to interview Dr. Mohd Moin Khan and Dr. Mudassir Meraj Banday, research fellows at Harvard University, about their research, this collaboration, and how we could use biosensors in the future to help predict the likelihood of rejection in organ transplants. Below are their answers to our questions.
Kicking-off saliva based Parkinson’s disease detection study using E-TRF and biosensors – Interview with Professor Valtteri Kaasinen from University of Turku
Aqsens Health is excited to take part in a cross-disciplinary Parkinson’s disease study in collaboration with Professor Valtteri Kaasinen from The Department of Clinical Neurosciences at the University of Turku. The aim of the study is to improve Parkinson’s disease’s diagnostic accuracy with Aqsens’ E-TRF and biosensor technology and smell detection dogs. We had the pleasure to interview Professor Kaasinen about Parkinson’s disease (PD), its diagnostics, and how this study could help improve diagnostics in the future.
Professor Tambet Teesalu joins Aqsens Health’s scientific advisors as a Senior Advisor in biosensor technology
Aqsens Health is happy to share that our scientific advisory team will be strengthened with Professor Tambet Teesalu’s phage and biosensor expertise.
How AI is shaping the Medtech industry – Interview with Professor Wei Dongqing from Shanghai Jiao Tong University
We at Aqsens Health had the opportunity to interview Professor Wei Dongqing to discuss how AI is shaping the future of the healthcare industry ahead of Aqsens and Shanghai Jiao Tong University's upcoming research collaboration.
Aqsens Health and OG Pharmaceuticals partner for an upcoming collaborative research project – Interview with OG Pharmaceuticals Founder & CEO Dr. Zhao Wanzhou
Dr. Zhao answered shared his views about the upcoming collaboration with Aqsens Health, the benefits of urine-based detection, and applying new cancer screening solutions in China.